Stay updated on Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.

Latest updates to the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page's revision label was updated to v3.5.5, indicating a minor update to the entry rather than a change to study details.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page displays a new revision tag (v3.5.4) in place of the previous tag (v3.5.3), indicating a site version update rather than a change to study information.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page displays a new revision label v3.5.3, replacing the previous v3.5.2. This reflects a small update to the page version without changing its visible content.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. There are no visible changes to the study details or how users interact with the page.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3, reflecting the addition of v3.4.3 and removal of v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.